Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
EYPT

EyePoint, Inc. (EYPT)

NASDAQ
$0.28
-$0.02
(-6.96%)
Previous Close: ⁦$0.30⁩
Market Closed

Last updated: ⁦2026-11-19 06:07:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

EyePoint, Inc. (EYPT) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $0.28, with a market capitalization of $35.00M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.27 to $19.11. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$35.00M

$0.30

$0.32

$0.27

$0.30

2.86M

8.57M

--

$19.11

$0.27

--

2026-09-30

EyePoint, Inc. (EYPT) Latest Closing Stock Price

EyePoint, Inc. (EYPT) last closed at $0.28 as of 2026-11-19 00:59:00, down 6.96% ($0.02) from the previous close of $0.30.

During the latest regular trading session, EYPT traded between $0.27 and $0.32, with a volume of 2.86M shares. The closing price was near the lower end and near the lower end of its 52-week range.

EyePoint, Inc. (EYPT) 7-Day Stock Price Change

Over the past seven days, EyePoint, Inc. (EYPT) moved from $0.36 to $0.28, representing a decline of 23.74% ($0.09).

The stock traded between $0.27 and $0.41 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 5.12 million shares, up versus the previous seven-day period, indicating higher trading activity.

EYPT 52-Week Price Position

Position in Range: 0.1%

52W Low$0.27
52W High$19.11

EYPT is currently trading at $0.28, placing it 0.1% of the way from its 52-week low of $0.27 to its 52-week high of $19.11. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is EyePoint, Inc. (EYPT)?

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

EyePoint, Inc. Information

Industry
LABORATORY ANALYTICAL INSTRUMENTS
Employees
214
Exchange
NASDAQ
Company Website

EYPT News

Latest news related to EyePoint, Inc. and EYPT stock.

  • Benzinga

    Stifel Maintains Buy on EyePoint, Lowers Price Target to $5

    Stifel analyst Annabel Samimy maintains EyePoint (NASDAQ:EYPT) with a Buy and lowers the price target from $6 to $5.

    Read Full Article
  • Benzinga

    12 Health Care Stocks Moving In Thursday's After-Market Session

    Gainers Oragenics (AMEX:OGEN) stock increased by 30.2% to $0.46 during Thursday's after-market session. The market value of their outstanding shares is at $1.5 million. InspireMD (NASDAQ:NSPR) shares rose 13.88%

    Read Full Article
  • Benzinga

    EyePoint Pharmaceuticals Q3 2026 Earnings Call Transcript

    EyePoint Pharmaceuticals (NASDAQ:EYPT) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by

    Read Full Article
  • Massive

    EyePoint (EYPT) Reports Q3 Loss, Beats Revenue Estimates

    EyePoint (EYPT) reported a quarterly loss of $1.07 per share, missing the consensus estimate of $0.88, representing a -21.59% earnings surprise. The company's stock has declined 98.1% year-to-date versus the S&P 500's 11.3% gain. Despite beating revenue estimates, the company maintains a Zacks Rank #3 (Hold) rating with mixed estimate revisions. AnaptysBio (ANAB), a peer in the Medical - Biomedical and Genetics industry, is expected to report earnings of $0.41 per share with revenues down 58% year-over-year.

    Read Full Article
  • Benzinga

    EyePoint Pharmaceuticals Q3 EPS $(1.07) Misses $(0.91) Estimate, Sales $756.000K Beat $223.077K Estimate

    EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate of $(0.91) by 17.58 percent. This is a 25.88 percent decrease over losses of $(0.85) per

    Read Full Article

Ways to Trade EYPT at MEXC

EYPT MEXC RealStocks

Own real EYPT shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy EyePoint, Inc. (EYPT) Stock on MEXC

Eligible investors can buy real shares of EyePoint, Inc. (EYPT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for EYPT and Place Your Order
Step 3: Search for EYPT and Place Your Order
Open the RealStocks trading page and search for EYPT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is EyePoint, Inc. (EYPT) stock price today?
EyePoint, Inc. (EYPT) is currently trading at $0.28, down 6.96% ($0.02) from the previous close of $0.30. Intraday prices update in real time during regular trading hours.
2.Is EYPT stock going up or down today?
As of 2026-11-19 00:59:00, EYPT is trading at $0.28, down 6.96% ($0.02) from its previous close of $0.30. The stock has traded between $0.27 and $0.32 during today’s regular session. Past price movements do not guarantee future results.
3.What is EYPT pre-market price?
As of 2026-11-19 00:59:00, EYPT is trading at $0.31 in pre-market trading, up 3.75% ($0.01) from the previous close of $0.30. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is EYPT after-hours price?
As of 2026-11-19 00:59:00, EYPT is trading at $0.28 in after-hours trading, down 0.36% ($0.00) from the regular-session close of $0.28. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is EYPT stock trading now?
EYPT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does EYPT sit relative to its 52-week high and low?
Over the past 52 weeks, EYPT has traded between a low of $0.27 and a high of $19.11. At $0.28, the stock is positioned 0.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is EyePoint, Inc. in?
EyePoint, Inc. (EYPT) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is EyePoint, Inc.'s market capitalization and where is it listed?
EyePoint, Inc. is listed on the NASDAQ exchange with a market capitalization of $35.00M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is EYPT valued in terms of P/E ratio and EPS?
EYPT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-3.01. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does EyePoint, Inc. pay a dividend?
EyePoint, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to EYPT, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

EYPT Stock Calculator

Estimate the value between EYPT shares and USD.

EYPT Shares to USD

EYPT Shares
EYPT
EYPT
USD
USD
USD

1.00 EYPT shares = 0.276 USD

Calculations are estimates based on the latest available price and are for reference only.